Volume 54, Issue 4, Pages (October 1998)

Slides:



Advertisements
Similar presentations
Type II Collagen Autoimmunity in Rheumatoid Arthritis
Advertisements

Volume 86, Issue 3, Pages (September 2014)
Steven Fishbane, Jeffrey S. Berns, M.D.  Kidney International 
Volume 59, Issue 3, Pages (March 2001)
Volume 61, Issue 1, Pages (January 2002)
Volume 66, Issue 4, Pages (October 2004)
Interleukin-2 as a marker for detecting asymptomatic individuals in areas where Leishmania infantum is endemic  A.V. Ibarra-Meneses, E. Carrillo, C. Sánchez,
Volume 70, Issue 8, Pages (October 2006)
Cerebrospinal fluid cytokines in enterovirus 71 brain stem encephalitis and echovirus meningitis infections of varying severity  S.-M. Wang, H.-Y. Lei,
Interleukin-10 Downregulates Anti-Microbial Peptide Expression in Atopic Dermatitis  Michael D. Howell, Natalija Novak, Thomas Bieber, Saveria Pastore,
IL-36γ Is Involved in Psoriasis and Allergic Contact Dermatitis
Red blood cell life span and ‘erythropoietin resistance’
Germaine Wong, Jeremy R. Chapman, Jonathan C. Craig 
The Th17 immune response in renal inflammation
Role of the T-cell interferon-gamma release assays in preventing reactivation of latent tuberculosis infection in immunosuppressed patients in treatment.
Genetic influence on cytokine production in meningococcal disease
Figure 2 Anti-LINGO-1 (Li81) does not affect cytokine production
Volume 56, Issue 3, Pages (September 1999)
Genetic influence on cytokine production in meningococcal disease
Yiping Wang, Yuet-Ching Tay, David C.H. Harris  Kidney International 
Dysregulation of LDL receptor under the influence of inflammatory cytokines: A new pathway for foam cell formation1  Dr Xiong Z. Ruan, Zac Varghese, Stephen.
Serum concentrations of interleukin-2R (IL-2R), IL-6, IL-8, and tumor necrosis factor alpha in patients with ectopic pregnancy  David Soriano, M.D., Danielle.
Volume 66, Issue 4, Pages (October 2004)
Volume 56, Issue 4, Pages (October 1999)
Interleukin-2 as a marker for detecting asymptomatic individuals in areas where Leishmania infantum is endemic  A.V. Ibarra-Meneses, E. Carrillo, C. Sánchez,
Volume 65, Issue 4, Pages (April 2004)
Volume 85, Issue 3, Pages (March 2014)
T-cell responses against tuberculin and sensitin in children with tuberculosis and non- tuberculosis mycobacterial lymphadenopathy  K. Magdorf, S.D. Schuck,
Volume 18, Issue 4, Pages (April 2010)
Volume 59, Issue 3, Pages (March 2001)
D. Coyne  Kidney International  Volume 69, Pages S1-S3 (May 2006)
Cannabinoid Reduces Inflammatory Cytokines, Tumor Necrosis Factor-α, and Type I Interferons in Dermatomyositis In Vitro  Elizabeth S. Robinson, Paul Alves,
Volume 93, Issue 1, Pages (January 2018)
Regulation of intestinal epithelial gene expression in hypoxia
Blood pressure targets in hemodialysis patients
Frank Eitner, Jürgen Floege  Kidney International 
Effect of anemia and renal cytokine production on erythropoietin production during blood-stage malaria  Kai-Hsin Chang, Mary M. Stevenson  Kidney International 
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 74, Issue 8, Pages (October 2008)
Juan M. Lopez-Gomez, Eduardo Verde, Rafael Perez-Garcia 
Volume 56, Issue 4, Pages (October 1999)
A.K.I. Kuroki, Masayuki Iyoda, Takanori Shibata, Tetsuzo Sugisaki 
Volume 55, Issue 4, Pages (April 1999)
Volume 60, Issue 6, Pages (December 2001)
Figure 3 Cytokine gene expression in PBMC stimulated with PPD or MBP in vitroCytokine messenger RNA transcripts were isolated from peripheral blood mononuclear.
Circadian regulation of renal function
Volume 64, Issue 6, Pages (December 2003)
Volume 54, Issue 5, Pages (November 1998)
Serum cystatin C-immunoglobulin high-molecular-weight complexes in kidney and liver transplant patients  Jesús Hermida, Rafael Romero, J. Carlos Tutor 
Daily nocturnal home hemodialysis
Current status of maintenance hemodialysis in Beijing, China
Organ transplantation goes to the movies
Volume 65, Issue 2, Pages (February 2004)
Volume 56, Pages S84-S87 (November 1999)
Volume 68, Pages S98-S102 (December 2005)
David A. Ferenbach, David C. Kluth, Jeremy Hughes  Kidney International 
Volume 70, Issue 3, Pages (August 2006)
Importance of blood pressure control in hemodialysis patient survival
Sundararaman Swaminathan, Matthew D. Griffin  Kidney International 
Volume 64, Issue 3, Pages (September 2003)
Adiponectin: good, bad, or just plain ugly?
Sotirios Tsiodras, MD, MSc, ScD, George Samonis, MD, Dimitrios T
Volume 59, Issue 3, Pages (March 2001)
Strategies for iron supplementation: Oral versus intravenous
Evaluation of the Losartan in Hemodialysis (ELHE) Study
Tumor necrosis factor-α in cisplatin nephrotoxicity: A homebred foe?
Development and differentiation of endothelium
Stephen Pastan, J. Michael Soucie, William M. McClellan 
Volume 74, Pages S4-S9 (December 2008)
Presentation transcript:

Volume 54, Issue 4, Pages 1337-1343 (October 1998) Role of cytokines in the response to erythropoietin in hemodialysis patients  Marian Goicoechea, Julio Martin, Patricia de Sequera, Juan A. Quiroga, Alberto Ortiz, Vicente Carreño, Carlos Caramelo  Kidney International  Volume 54, Issue 4, Pages 1337-1343 (October 1998) DOI: 10.1046/j.1523-1755.1998.00084.x Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 1 (A) Interleukin-12 (IL-12) production by peripheral blood mononuclear cells (PBMC) in groups A1, A2, B1and B2. The cutoff was 60 U/kg/week for groups A1 and B1, and the cutoff was 100 U/kg/week for groups A2 and B2. (B) Interferon gamma (IFN-γ) production by PBMC in groups A1, A2, B1 and B2. The cutoff was 60 U/kg/week for groups A1 and B1, and the cutoff was 100 U/kg/week for groups A2 and B2. (C) Tumor necrosis factor alpha (TNF-α) production by PBMC in groups A1, A2, B1 and B2. The cutoff was 60 U/kg/week for groups A1 and B1, and the cutoff was 100 U/kg/week for groups A2 and B2. Symbols are: () group A; (▪) group B. Kidney International 1998 54, 1337-1343DOI: (10.1046/j.1523-1755.1998.00084.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 2 Human recombinant erythropoietin (EPO) requirements in the group of patients with tumor necrosis factor-α (TNF-α) < 2 and interleukin-6 (IL-6) production < 40 (N = 11; ) versus the group of patients with TNF-α ≥ 2ng/ml and IL-6 production ≥ 40ng/ml (N = 14; ▪). Kidney International 1998 54, 1337-1343DOI: (10.1046/j.1523-1755.1998.00084.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 3 Relationship between interleukin-6 (IL-6) production by peripheral blood mononuclear cells (PBMC) and erythropoietin (EPO) requirements in 34 hemodialysis subjects (r = 0.384, P = 0.039). Kidney International 1998 54, 1337-1343DOI: (10.1046/j.1523-1755.1998.00084.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 4 Relationship between tumor necrosis factor-α (TNF-α) production by peripheral blood mononuclear cells (PBMC) and erythropoietin (EPO) requirements in 34 hemodialysis subjects (r = 0.379, P = 0.02). Kidney International 1998 54, 1337-1343DOI: (10.1046/j.1523-1755.1998.00084.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 5 Relationship between interleukin (IL)-12 production by peripheral blood mononuclear cells (PBMC) and erythropoietin (EPO) requirements in 34 hemodialysis subjects (r = 0.378, P = 0.029). Kidney International 1998 54, 1337-1343DOI: (10.1046/j.1523-1755.1998.00084.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 6 Schematic view of the network of cytokines interactions involved in the deranged regulation of the hemopoiesis. The positive or negative regulations are indicated in the balloons. Data from17,18,26-28 plus the results of our study were combined to draw the cartoon. Kidney International 1998 54, 1337-1343DOI: (10.1046/j.1523-1755.1998.00084.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Kidney International 1998 54, 1337-1343DOI: (10. 1046/j. 1523-1755 Kidney International 1998 54, 1337-1343DOI: (10.1046/j.1523-1755.1998.00084.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Kidney International 1998 54, 1337-1343DOI: (10. 1046/j. 1523-1755 Kidney International 1998 54, 1337-1343DOI: (10.1046/j.1523-1755.1998.00084.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Kidney International 1998 54, 1337-1343DOI: (10. 1046/j. 1523-1755 Kidney International 1998 54, 1337-1343DOI: (10.1046/j.1523-1755.1998.00084.x) Copyright © 1998 International Society of Nephrology Terms and Conditions